Tony Weisman - 12 Dec 2024 Form 4 Insider Report for Klaviyo, Inc. (KVYO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Dec 2024, 20:47:49 UTC
Prior SEC filing
13 Jun 2024
Next SEC filing
11 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Landon Edmond, Attorney-in-Fact

Key filing fact

Tony Weisman filed Form 4 for Klaviyo, Inc. (KVYO) on 13 Dec 2024.

Key facts

  • This page summarizes Tony Weisman's Form 4 filing for Klaviyo, Inc. (KVYO).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 13 Dec 2024, 20:47.

Change

  • Previous filing in this sequence was filed on 13 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KVYO transaction

Series A Common Stock

Conversion of derivative security

Transaction value
Shares
+75,000
Change %
+879%
Price
Shares after
83,532
Date
12 Dec 2024
Ownership
Direct
Footnotes
F1, F2
KVYO transaction

Series A Common Stock

Conversion of derivative security

Transaction value
Shares
+20,833
Change %
Price
Shares after
20,833
Date
12 Dec 2024
Ownership
By trust
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KVYO transaction Derivative

Series B Common Stock

Conversion of derivative security

Transaction value
$0
Shares
-75,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Dec 2024
Ownership
Direct
Underlying class
Series A Common Stock
Underlying amount
75,000
Exercise price
Footnotes
F1
KVYO transaction Derivative

Series B Common Stock

Conversion of derivative security

Transaction value
$0
Shares
-20,833
Change %
-100%
Price
$0.000000
Shares after
0
Date
12 Dec 2024
Ownership
By trust
Underlying class
Series A Common Stock
Underlying amount
20,833
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each share of the Issuer's Series B Common Stock, par value $0.001 per share ("Series B Common Stock"), is convertible at any time at the option of the holder into one share of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and will automatically convert into shares of Series A Common Stock upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation. The Series B Common Stock has no expiration date.

Footnote F2

Consists of (i) 75,000 shares of Series A Common Stock and (ii) 8,532 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.

Footnote F3

Shares held by Tony G. Weisman TTEE Tony G. Weisman Declaration of Trust Dated 06-27-2000, of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the such shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed to be an admission that he has beneficial ownership of such shares for Section 16 or any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .